On July 30, 2026, Nasdaq notified the company that its securities will be delisted after the closing bid price was $0.10 or less for ten consecutive trading days, triggering Listing Rule 5810(c)(3)(A)(iii). Trading will be suspended at the opening on August 6, 2026, and a Form 25-NSE will be filed…
Proposed acquisition, valued at $42 million, could add over $35 million in annualized revenue and more than $7 million in earningsHOUSTON, TX / ACCESS Newswire / July 29, 2026 / VSee Health, Inc. NASDAQ:VSEE ("VSee" or the "Company"), a leading provider of telehealth technology and digital health s…
HOUSTON, TX / ACCESS Newswire / July 22, 2026 / VSee Health, Inc. NASDAQ:VSEE ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today reaffirmed its commitment to protecting shareholder value by minimizing dilution while maintaining the financial flexibility…
VSee Health entered two unsecured convertible note financings totaling $575,550 to strengthen liquidity. The company issued a $280,000 note to ClearThink with a one-time 10% interest charge, and a $295,550 note to Vanquish with a one-time 12% interest charge. The ClearThink note matures on Jun 22…
